2,6-Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)pyridine, 95.0%, 250mg

2-(4-Bromophenyl)propan-2-amine hydrochloride, 95.0%, 1g

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, 95.0%, 1g

(2R,4S,5R)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 98%, 1g

2-(n-Methyl-1-phenylformamido)acetic acid, 98%, 25g

5H-Pyrrolo[2,3-b]pyrazine-6-carboxylic acid, 95.0%, 1g

4-(4-Fluoro-phenyl)-3-oxo-butyric acid ethyl ester, 5g

D-glucuronic acid sodium salt monohydrate, min. 99%, for biochemistry, 25 g, glass packaging

(2R,3R)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXY-2-METHYL-4-(1H-1,2,4-TRIAZOL-1-YL)BUTANETHIOAMIDE, 97.0%, 250mg

N-[(1S,2S)-2,3-Dihydro-2-[(2-methoxy-6-methylphenyl)thio]-1H-inden-1-yl]-1,1,1-trifluoromethanesulfonamide, 50mg

3-BROMOMETHYL-5-FURAN-2-YL-ISOXAZOLE, 95.0%, 250mg

Methyl 2-hydroxy-3-methylbutanoate, 97%, 5g

2-Ethylpiperidin-4-one hydrochloride, 98%, 250mg